Neil Barber, Simon Bott and Richard Hindley were all involed in this latest study published in the European Urology Oncology Journal. At Urology Partners, we only use targeted biopsies for diagnosing prostate cancer to get the most accurate diagsnosis for our patients. As well as detecting prostate cancer, the fusion targted approach enables us to differentiate between clinically significant and non significant cancers to enable patients to get the best treatment possible and avoid over diagnosis and unnecessary concern for patients.